We are pleased to announce that our CEO, Jan Hendriks, will be representing our company at the highly anticipated BIO CEO & Investor Conference in New York City on February 27-28!
The BIO CEO & Investor Conference is renowned for bringing together top-tier investors, industry analysts, and senior biotech leaders to discuss the latest trends and opportunities in the biotechnology sector. With a focus on both established and emerging companies, this event plays a crucial role in shaping the future of biotech investments and ultimately contributing to better patient outcomes.
If you’re attending the conference and would like to learn more about the potential of MTC-Y—a groundbreaking transdermal carrier developed by our team—please reach out. We’d love to connect and explore exciting opportunities together. Don’t miss the chance to schedule a meeting with Jan Hendriks to discuss how MTC-Y can revolutionize biotech innovation!